🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Antiphospholipid Syndrome

A Clinical Study of YTS109 Cell in R/R Autoimmune Diseases NCT06978647Phase 11 site📍 Beijing China Immunotech (Beijing) Biotechnology Co., Ltd. · Tests: YTS109 cell BCMA-CD19 CAR-T Therapy for Refractory Autoimmune Diseases NCT06794008Phase 21 site📍 Beijing Peking University People's Hospital · Tests: BCMA-CD19 CAR-T therapy Follow-up Cohort of Patients With Antiphospholipid Syndrome NCT07178925n/a1 site📍 Rouen University Hospital, Rouen · Tests: Study of Antiphospholipid Syndrome responding to the Sydney classification of 2006 Genetic Risk Factors Associated With Antiphospholipid Antibody Syndrome NCT00482794n/a1 site📍 Durham Duke University A Clinical Study of YTS109 Cell for R/R Autoimmune Diseases NCT07104721Phase 11 site📍 Hefei China Immunotech (Beijing) Biotechnology Co., Ltd. · Tests: YTS109 cell Clinical Study of BCT301 Cell Injection Therapy for Refractory Autoimmune Diseases NCT07301164EARLY Phase 11 site📍 Beijing Peking University Third Hospital · Tests: BCT301 Negative Antiphospholipid Syndrome: a Multicentric Study NCT06373003n/a1 site📍 Roma Italian Society for Rheumatology · Tests: Diagnostic accuracy Effect of Belimumab on Antibody Titers in Primary APS Patients NCT06747312Phase 21 site📍 Shanghai Ruijin Hospital · Tests: Belimumab+SOC, SOC Phase 1 Study of HBI0101 CAR-T in Refractory B-Cell Autoimmune Diseases NCT07085676Phase 11 site📍 Jerusalem Polina Stepensky · Tests: HBI0101 CART Laboratory and Clinical Data in Antiphospholipid Patients NCT04308564n/a2 sites📍 Lille📍 Nancy Central Hospital, Nancy, France · Tests: Blood test Anti-CD19 IL-10/IL15 CAR-NK Cells in Refractory/Relapsed Autoimmune Diseases NCT06614270NA1 site📍 Hangzhou Second Affiliated Hospital, Zhejiang University, School of … · Tests: Anti-CD19 IL-10/IL15 CAR-NK An Clinical Study of YTS109 Cell Injection in Subjects With Recurrent/Refractory Autoimmune Disease NCT06379646NA1 site📍 Shanghai China Immunotech (Beijing) Biotechnology Co., Ltd. · Tests: YTS109 Armenian NAtionwide REGistry of Systemic Autoimmune and Autoinflammatory Diseases NCT05904301n/a6 sites📍 Yerevan📍 Yerevan📍 Yerevan Santé Arménie French-Armenian Research Center · Tests: Usual medical management of patients, additional blood and stool samples for biobanking Prevalence and Consequences of Antiphospholipid Syndrome in Patients Aged 65 and Over With Ischemic Strokes (IS) NCT07163338NA1 site📍 Reims CHU de Reims · Tests: Collectio nof blood Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial) NCT06371417Phase 177 sites📍 Orange📍 Baltimore📍 Lake Success Chugai Pharmaceutical · Tests: RAY121 Rheumatology Patient Registry and Biorepository NCT04402086n/a1 site📍 New Haven Yale University Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic Diseases NCT07087912Phase 42 sites📍 São Paulo📍 São Paulo University of Sao Paulo General Hospital · Tests: Dengue 1,2,3,4 (attenuated) vaccine Safety and Efficacy of Universal CD19-targeting CAR-γδT Cells in Refractory Autoimmune Diseases NCT06828042Phase 1, Phase 21 site📍 Beijing Peking University Third Hospital · Tests: anti-CD19 CAR T cell therapy Register for Pediatric Patients With Antiphospholipid Syndrome (APS): European Project Extended Internationally Study NCT00616317n/a1 site📍 Sacramento University of California, Davis Observational Study to Evaluate the Effectiveness of DOACS for Secondary Thrombosis Prevention in Low-risk Thrombotic APS Patients NCT07372170n/a2 sites📍 Madrid📍 Madrid Infanta Leonor University Hospital Thrombocytopenia Trajectories in Antiphospholipid Syndrome: A Multicenter Cohort Study NCT07757789NA1 site📍 Al Khārjah New Valley University · Tests: Platelet count International Registry of Thrombotic APS Patients Treated With Direct Oral Anticoagulants NCT04262492n/a1 site📍 Nancy Stéphane Zuily · Tests: Rivaroxaban Antiphospholipid Syndrome and Postpartum Pulmonary Artery Pressure NCT05679206n/a1 site📍 Bern Insel Gruppe AG, University Hospital Bern · Tests: Echocardiography images, 24-hour ambulatory blood pressure monitoring Chinese AntiphosPholipid Syndrome cohorT cOllaborative NEtworks NCT05230017n/a18 sites📍 Beijing📍 Beijing📍 Fuzhou Peking Union Medical College Hospital Patients Pregnant Women With or Without Primary Antiphospholipid Antibody Syndrome NCT05786235n/a1 site📍 Milan IRCCS San Raffaele · Tests: Collection of epidemiological and anamnestic data and collection of biological material (peripheral blood), Collection … Hematological Markers MPV, PLR, and NLR in Primary Versus Secondary Antiphospholipid Syndrome NCT07142239n/a1 site📍 Al Khārjah New Valley University · Tests: • Complete blood count , MPV, Calculation of PLR: Platelet count / Lymphocyte count and Calculation of NLR:, Antiphosph… Evaluation of Cell Membrane Expression of Annexin A2 on Monocytes by Flow Cytometry in Primary Antiphospholipid Syndrome NCT06373926NA1 site📍 Amiens Centre Hospitalier Universitaire, Amiens · Tests: blood withdrawal Autoimmune Hemolytic Anemia and Its Clinical Implication on Antiphospholipid Syndrome NCT07743242NA1 site📍 Al Khārjah New Valley University · Tests: Hemoglobin, Coombs test Predictors of Pregnancy Outcome in Systemic Lupus Erythematosus (SLE) and Antiphospholipid Syndrome (APS) NCT00198068n/a10 sites📍 Chicago📍 Chicago📍 Baltimore Hospital for Special Surgery, New York Registry on Augmented Antithrombotic Treatment Regimens for Patients With Arterial Thrombotic APS NCT05646394n/a3 sites📍 Buenos Aires📍 Córdoba📍 Hamilton McMaster University · Tests: Dual antiplatelet therapy, Combined antithrombotic therapy, Vitamin K antagonist standard intensity, Vitamin K antagoni…
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy